UK Doctors Used Stem Cells to Restore Eyesight in Two People – Gizmodo
Gizmodo |
UK Doctors Used Stem Cells to Restore Eyesight in Two People
Gizmodo Two elderly patients with macular degeneration at Moorfields Eye Hospital in London were given a cutting-edge stem cell therapy as part of a small trial to improve vision for people with sudden and severe loss of vision caused by what’s known as “wet … New Stem Cell Treatment Reverses Vision Loss in 2 PatientsLive Science Patients regain sight with stem cell treatment in UK clinical trialCBS News New Stem Cell Treatment Gives Blind Patients Ability To ReadCBS Miami Newsweek –WebMD –Atlanta Journal Constitution –The Guardian all 117 news articles » |
Bio-IT World |
CRISPR Strategy & Standards: How Synthego’s Free Software Lays The Groundwork For CRISPR Futures
Bio-IT World March 21, 2018 | “Science really moves forward when things become easier to the scientist: when you don’t have to spend as much time doing something, or a new capability comes on the scene,” says Paul Dabrowski, CEO and co-founder of Synthego. CRISPR … |
Times of Malta |
Blood cancer survivor meets ‘genetic twin’ stem cell donor
Times of Malta Peter Milburn and Aysha Lord at the charity’s Let’s Make a Spark Award ceremony, as the father of four who survived blood cancer has met and thanked the “genetic twin” stem cell donor who saved his life. A father of four who survived blood cancer has … Blood cancer survivor meets `genetic twin´ stem cell donorInfosurhoy |
PR Newswire (press release) |
BioMarin’s Gene Therapy Manufacturing Facility Recognized with Industry Award
PR Newswire (press release) SAN RAFAEL, Calif., March 21, 2018 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the International Society for Pharmaceutical Engineering (ISPE) selected the company’s gene therapy manufacturing facility as the 2018 … |
Multiple Sclerosis News Today |
Blood Stem Cell Transplants Improve RRMS Patients’ Disability, Phase 3 Trial Shows
Multiple Sclerosis News Today Blood stem cell transplants lead to significant improvements in relapsing-remitting multiple sclerosis patients’ disability, a Phase 3 clinical trial shows. The 110 patients who took part in the MIST study (NCT00273364) were having relapses after … |
Multiple Sclerosis News Today |
Blood Stem Cell Transplants Improve RRMS Patients’ Disability, Phase 3 Trial Shows
Multiple Sclerosis News Today Blood stem cell transplants lead to significant improvements in relapsing-remitting multiple sclerosis patients’ disability, a Phase 3 clinical trial shows. The 110 patients who took part in the MIST study (NCT00273364) were having relapses after … |